Position
Fidelity in Monte Rosa Therapeutics, Inc.
Back to the book · All holders of GLUE
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $7.24M$16.45 → $24.20
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 1.3M | $20.4M | — | — | — | 0.0% |
| Q1 2026 | 1.02M | $16.8M | $16.45 | $788.7K | −$4.32M | 0.0% |
| Q2 2026 | 934.4K | $22.6M | $24.20 | $7.24M | −$1.48M | 0.0% |